Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-03

FDA Approved: BORTEZOMIB — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' generic Bortezomib through an Original Application (ANDA 212204). This approval makes a generic version of the proteasome i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bortezomib (bortezomib)

Snippet

ORIG AP for BORTEZOMIB (BORTEZOMIB)